AQR Capital Management
TNYA icon

AQR Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

AQR Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,748
Closed -$20.5K – 3820
2025
Q4 		$20.5K Sell
28,748
-130,871
-82% -$178K ﹤0.01% 3547
2025
Q3 		$259K Sell
159,619
-1,582,607
-91% -$1.59M ﹤0.01% 3152
2025
Q2 		$1.06M Buy
1,742,226
+966,569
+125% +$492K ﹤0.01% 2174
2025
Q1 		$442K Buy
+775,657
New +$765K ﹤0.01% 2493
2024
Q3 		– Sell
-13,978
Closed -$43.3K – 2874
2024
Q2 		$43.3K Sell
13,978
-4,936
-26% -$20.4K ﹤0.01% 2547
2024
Q1 		$98.9K Sell
18,914
-4,480
-19% -$21.4K ﹤0.01% 2340
2023
Q4 		$75.8K Buy
23,394
+8,649
+59% +$18.7K ﹤0.01% 2289
2023
Q3 		$37.6K Buy
+14,745
New +$61.7K ﹤0.01% 2293

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's TNYA Position: Q1 2026 in Review

AQR Capital Management sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 28,748 shares — an estimated $20.5K sold.

AQR Capital Management first reported a position in TNYA in Q3 2023 and held it in 8 quarters. The position peaked at $1.06M in Q2 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • AQR Capital Management reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AQR Capital Management sold 28,748 Tenaya Therapeutics shares in Q1 2026, an estimated $20.5K.
  • AQR Capital Management first reported a position in Tenaya Therapeutics in Q3 2023 and held it in 8 quarters.
  • AQR Capital Management's Tenaya Therapeutics position peaked at $1.06M in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.